TransAct Technologies Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results
2023 Fourth Quarter Net Sales of
Quarterly Food Service Technology (“FST”) Sales of
Quarterly Casino and Gaming Sales of
“This was a year of change here at TransAct, and I believe that the organization has emerged from this transition stronger, more efficient, and operationally more effective,” said John Dillon, Chief Executive Officer of TransAct. “On the FST side, we believe that we now have the right team in the right places selling to enterprise-level organizations with our new BOHA! Terminal 2, which has seen a solid reception from customers and prospects so far. We added twelve new logos to our BOHA! platform in the fourth quarter and sold 1,235 terminals, and believe that we have the opportunity to build momentum throughout the course of 2024.”
Fourth Quarter 2023 Financial Highlights
-
Net Sales: Net sales for the fourth quarter of 2023 were
, down$13.3 million 26% compared to for the fourth quarter of 2022.$18.0 million -
FST Recurring Revenue: FST recurring revenue for the fourth quarter of 2023 was
, up$3.2 million 33% compared to for the fourth quarter of 2022.$2.4 million -
Gross Profit: Gross profit for the fourth quarter of 2023 was
, resulting in gross margin of$6.4 million 48.0% , compared to gross profit of for the fourth quarter of 2022, which delivered a$8.2 million 45.8% gross margin. -
Operating income (loss): Operating loss for the fourth quarter of 2023 was
, compared to operating income of$(0.5) million for the fourth quarter of 2022.$0.5 million -
Net income (loss): Net loss for the fourth quarter of 2023 was
, or$(62) thousand per diluted share, based on 10.0 million weighted average common shares outstanding. Net income for the comparable 2022 period was$(0.01) , or$260 thousand per diluted share, based on 9.9 million weighted average common shares outstanding.$0.03 -
EBITDA: EBITDA was
for the fourth quarter of 2023, compared to$0.3 million for the fourth quarter of 2022.$1.0 million -
Adjusted EBITDA: Adjusted EBITDA was
for the fourth quarter of 2023, compared to$0.6 million for the fourth quarter of 2022.$1.3 million
Full Year 2023 Financial Highlights
-
Net Sales: Net sales for the full year 2023 were
, up$72.6 million 25% compared to for the full year 2022.$58.1 million -
FST Recurring Revenue: FST recurring revenue for the full year 2023 was
, up$11.1 million 28% compared to for the full year 2022.$8.7 million -
Gross Profit: Gross profit for the full year 2023 was
, resulting in gross margin of$38.4 million 52.9% , compared to gross profit of for the full year 2022, which delivered a$24.4 million 42.0% gross margin. -
Operating income (loss): Operating income for the full year 2023 was
, compared to an operating loss of$5.7 million for the full year 2022.$(7.7) million -
Net income (loss): Net income for the full year 2023 was
, or$4.7 million per diluted share, based on 10.0 million weighted average common shares outstanding. Net loss for the full year 2022 was$0.47 , or$(5.9) million per diluted share, based on 9.9 million weighted average common shares outstanding.$(0.60) -
Adjusted net income (loss): Adjusted net income for the full year 2023 was
, or$5.9 million per diluted share. Adjusted net loss for the full year 2022 was$0.59 , or$(5.9) million net loss per diluted share.$(0.60) -
EBITDA: EBITDA was
for the full year 2023, compared to an EBITDA loss of$7.6 million for the full year 2022.$(6.4) million -
Adjusted EBITDA: Adjusted EBITDA was
for the full year 2023, compared to an Adjusted EBITDA loss of$10.0 million for the full year 2022.$(5.2) million
Recent Development
The Company announced that it engaged a strategic advisor to assist in determining the best long-term strategy for its business.
2024 Financial Outlook
-
Total Net Sales: The Company currently expects full year 2024 total net sales of between
and$53 million .$58 million - Total Adjusted EBITDA: The Company currently expects full year 2024 total adjusted EBITDA to be approximately breakeven.
Our outlook for non-GAAP adjusted EBITDA is presented only on a non-GAAP basis because not all of the information necessary for a quantitative reconciliation of this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure is available without unreasonable effort, primarily due to uncertainties relating to the occurrence or amount of these adjustments that may arise in the future. If one or more of the currently unavailable items is applicable, some items could be material, individually or in the aggregate, to GAAP reported results.
2023 Fourth Quarter and Full Year Conference Call and Webcast
TransAct is hosting a conference call and webcast today, March 12, 2024, beginning at 4:30 p.m. ET to discuss the Company’s preliminary fourth quarter and full year 2023 results and other matters. Both the call and the webcast are open to the general public. The conference call number is 877-704-4453 and the conference ID number is 13744766 (domestic or international). Please call ten minutes prior to the presentation to ensure that you are connected.
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Investor Relations” followed by “Events & Presentations”). Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by investors to measure a company’s operating performance without regard to items that do not reflect the Company’s ongoing operations and are excluded from the calculation of such measure; (ii) used as financial measurements by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. Adjusted net income (loss) and adjusted net income (loss) per diluted share provide the Company with an understanding of the results of the primary operations of the business by excluding the effects of special items (for example, the
EBITDA is defined as net income (loss) before net interest expense, income taxes, depreciation, and amortization. A reconciliation of EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
Adjusted EBITDA is defined as net income (loss) before net interest expense, income taxes, depreciation and amortization and is adjusted for (1) share-based compensation, (2) the
Adjusted net income (loss) is defined as net income (loss) adjusted for (1) the
Adjusted net income (loss) per diluted share is defined as adjusted net income (loss) divided by diluted shares outstanding. A reconciliation of adjusted net income (loss) per diluted share to net income (loss) per diluted share, the most comparable GAAP financial measure, can be found attached to this release.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a global leader in developing and selling software-driven technology and printing solutions for high-growth markets including food service, casino and gaming, and POS automation. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the BOHA!™, AccuDate™, EPICENTRAL®, Epic and Ithaca® brands. TransAct has sold over 3.9 million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts, and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in
©2024 TRANSACT Technologies Incorporated. All rights reserved. TransAct®, BOHA!™, AccuDate™, Epic Edge®, EPICENTRAL® and Ithaca® are trademarks of TransAct Technologies Incorporated.
Cautionary Statement Regarding Preliminary Financial Information
The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical financial information and in good faith based upon its internal reporting as of and for the three months and full year ended December 31, 2023. This financial information is preliminary and is thus inherently uncertain and subject to change as the Company finalizes its financial results and related review for the three months and audit for the full year ended December 31, 2023. During the course of the preparation of the Company’s consolidated financial statements and related notes as of and for the three months and full year ended December 31, 2023, the Company may identify items that could cause its final reported results to be materially different from the preliminary financial information set forth above. As a result, there can be no assurance that the Company’s final results for this period will not differ from the preliminary financial information.
This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.
Forward-Looking Statements
Certain statements included in this press release may be forward-looking statements within the meaning of the
- Financial tables follow-
TRANSACT TECHNOLOGIES INCORPORATED |
||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||
(Preliminary and Unaudited) |
||||||||||||
|
|
|||||||||||
|
|
Three months ended |
|
Year ended |
||||||||
|
|
December 31, |
|
December 31, |
||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
|
(In thousands, except per share data) |
||||||||||
|
|
|
|
|
|
|
|
|
||||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
6,894 |
|
|
9,739 |
|
|
34,231 |
|
|
33,727 |
|
Gross profit |
|
6,371 |
|
|
8,219 |
|
|
38,400 |
|
|
24,412 |
|
|
|
|
|
|
|
|
|
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
||||
Engineering, design and product development |
|
2,159 |
|
|
2,130 |
|
|
9,442 |
|
|
8,570 |
|
Selling and marketing |
|
2,096 |
|
|
2,602 |
|
|
9,934 |
|
|
11,326 |
|
General and administrative |
|
2,638 |
|
|
2,993 |
|
|
13,318 |
|
|
12,193 |
|
|
|
6,893 |
|
|
7,725 |
|
|
32,694 |
|
|
32,089 |
|
Operating (loss) income |
|
(522 |
) |
|
494 |
|
|
5,706 |
|
|
(7,677 |
) |
|
|
|
|
|
|
|
|
|
||||
Interest and other income (expense): |
|
|
|
|
|
|
|
|
||||
Interest, net |
|
(48 |
) |
|
(63 |
) |
|
(255 |
) |
|
(208 |
) |
Other, net |
|
474 |
|
|
151 |
|
|
452 |
|
|
(16 |
) |
|
|
426 |
|
|
88 |
|
|
197 |
|
|
(224 |
) |
|
|
|
|
|
|
|
|
|
||||
(Loss) income before income taxes |
|
(96 |
) |
|
582 |
|
|
5,903 |
|
|
(7,901 |
) |
Income tax benefit (expense) |
|
34 |
|
|
(322 |
) |
|
(1,155 |
) |
|
1,965 |
|
Net (loss) income |
|
|
) |
|
|
|
|
|
|
|
|
) |
|
|
|
|
|
|
|
|
|
||||
Net (loss) income per common share: |
|
|
|
|
|
|
|
|
||||
Basic |
|
|
) |
|
|
|
|
|
|
|
|
) |
Diluted |
|
|
) |
|
|
|
|
|
|
|
|
) |
|
|
|
|
|
|
|
|
|
||||
Shares used in per share calculation: |
|
|
|
|
|
|
|
|
||||
Basic |
|
9,958 |
|
|
9,912 |
|
|
9,951 |
|
|
9,905 |
|
Diluted |
|
9,958 |
|
|
9,921 |
|
|
10,021 |
|
|
9,905 |
|
SUPPLEMENTAL INFORMATION – SALES BY MARKET: (Preliminary and Unaudited) |
||||||||||||
|
Three months ended |
|
Year ended |
|||||||||
|
December 31, |
|
December 31, |
|||||||||
|
2023 |
2022 |
|
2023 |
2022 |
|||||||
|
(In thousands) |
|||||||||||
|
|
|
|
|
|
|||||||
Food service technology |
|
|
|
|
|
|||||||
POS automation |
1,577 |
2,959 |
|
6,922 |
10,659 |
|||||||
Casino and gaming |
4,190 |
10,999 |
|
41,192 |
30,029 |
|||||||
TransAct Services Group |
2,784 |
946 |
|
8,209 |
5,087 |
|||||||
Total net sales |
|
|
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED |
||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
(Preliminary and Unaudited) |
||||||
|
|
|
|
|
||
|
|
December 31, |
|
December 31, |
||
|
|
2023 |
|
|
2022 |
|
|
|
(In thousands) |
||||
Assets: |
|
|
|
|
||
Current assets: |
|
|
|
|
||
Cash and cash equivalents |
|
|
|
|
|
|
Accounts receivable, net |
|
9,824 |
|
|
13,927 |
|
Employee retention credit receivable |
|
- |
|
|
1,500 |
|
Inventories |
|
17,759 |
|
|
12,028 |
|
Other current assets |
|
1,095 |
|
|
724 |
|
Total current assets |
|
40,999 |
|
|
36,125 |
|
|
|
|
|
|
||
Fixed assets, net |
|
2,421 |
|
|
2,781 |
|
Right-of-use assets, net |
|
1,602 |
|
|
2,488 |
|
Goodwill |
|
2,621 |
|
|
2,621 |
|
Deferred tax assets |
|
6,304 |
|
|
7,327 |
|
Intangible assets, net |
|
88 |
|
|
242 |
|
Other assets |
|
163 |
|
|
248 |
|
|
|
13,199 |
|
|
15,707 |
|
Total assets |
|
|
|
|
|
|
|
|
|
|
|
||
Liabilities and Shareholders’ Equity: |
|
|
|
|
||
Current liabilities: |
|
|
|
|
||
Revolving loan payable |
|
|
|
|
|
|
Accounts payable |
|
4,431 |
|
|
7,395 |
|
Accrued liabilities |
|
4,947 |
|
|
4,077 |
|
Lease liabilities |
|
929 |
|
|
875 |
|
Deferred revenue |
|
1,079 |
|
|
1,329 |
|
Total current liabilities |
|
13,636 |
|
|
15,926 |
|
|
|
|
|
|
||
Deferred revenue, net of current portion |
|
209 |
|
|
143 |
|
Lease liabilities, net of current portion |
|
720 |
|
|
1,683 |
|
Other liabilities |
|
219 |
|
|
218 |
|
|
|
1,148 |
|
|
2,044 |
|
Total liabilities |
|
14,784 |
|
|
17,970 |
|
|
|
|
|
|
||
Shareholders’ equity: |
|
|
|
|
||
Common stock |
|
140 |
|
|
139 |
|
Additional paid-in capital |
|
57,055 |
|
|
56,282 |
|
Retained earnings |
|
14,378 |
|
|
9,630 |
|
Accumulated other comprehensive loss, net of tax |
|
(49 |
) |
|
(79 |
) |
Treasury stock, at cost |
|
(32,110 |
) |
|
(32,110 |
) |
Total shareholders’ equity |
|
39,414 |
|
|
33,862 |
|
Total liabilities and shareholders’ equity |
|
|
|
|
|
|
|
|
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED |
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING NON-GAAP FINANCIAL MEASURES |
(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts) |
|
|
Three months ended December 31, 2023 |
||||||
|
|
Reported |
|
Adjustments(1) |
|
Adjusted Non-GAAP |
||
Operating expenses |
|
|
|
|
$- |
|
|
|
% of net sales |
|
52.0 |
% |
|
|
|
52.0 |
% |
|
|
|
|
|
|
|
||
Operating loss |
|
(522 |
) |
|
- |
|
(522 |
) |
% of net sales |
|
(3.9 |
)% |
|
|
|
(3.9 |
)% |
|
|
|
|
|
|
|
||
Interest and other income |
|
426 |
|
|
- |
|
426 |
|
Loss before income taxes |
|
(96 |
) |
|
- |
|
(96 |
) |
Income tax benefit |
|
34 |
|
|
- |
|
34 |
|
Net loss |
|
(62 |
) |
|
- |
|
(62 |
) |
Net loss per common share: |
|
|
|
|
|
|
||
Basic |
|
|
) |
|
$- |
|
|
) |
Diluted |
|
|
) |
|
$- |
|
|
) |
(1) No adjustments. |
|
|
Three months ended December 31, 2022 |
||||||
|
|
Reported |
|
Adjustments(2) |
|
Adjusted Non-GAAP |
||
Operating expenses |
|
|
|
|
$- |
|
|
|
% of net sales |
|
43.0 |
% |
|
|
|
43.0 |
% |
|
|
|
|
|
|
|
||
Operating income |
|
494 |
|
|
- |
|
494 |
|
% of net sales |
|
2.8 |
% |
|
|
|
2.8 |
% |
|
|
|
|
|
|
|
||
Interest and other income |
|
88 |
|
|
- |
|
88 |
|
Income before income taxes |
|
582 |
|
|
- |
|
582 |
|
Income tax (expense) |
|
(322 |
) |
|
- |
|
(322 |
) |
Net income |
|
260 |
|
|
- |
|
260 |
|
Net income per common share: |
|
|
|
|
|
|
||
Basic |
|
|
|
|
$- |
|
|
|
Diluted |
|
|
|
|
$- |
|
|
|
(2) No adjustments. |
TRANSACT TECHNOLOGIES INCORPORATED |
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING NON-GAAP FINANCIAL MEASURES |
(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts) |
|
|
Year ended December 31, 2023 |
|||||||
|
|
Reported |
|
Adjustments(3) |
|
Adjusted Non-GAAP |
|||
Operating expenses |
|
|
|
|
|
) |
|
|
|
% of net sales |
|
45.0 |
% |
|
|
|
43.0 |
% |
|
|
|
|
|
|
|
|
|||
Operating income |
|
5,706 |
|
|
1,461 |
|
|
7,167 |
|
% of net sales |
|
7.9 |
% |
|
|
|
9.9 |
% |
|
|
|
|
|
|
|
|
|||
Interest and other income |
|
197 |
|
|
- |
|
|
197 |
|
Income before income taxes |
|
5,903 |
|
|
1,461 |
|
|
7,364 |
|
Income tax (expense) |
|
(1,155 |
) |
|
(303 |
) |
|
(1,458 |
) |
Net income |
|
4,748 |
|
|
1,158 |
|
|
5,906 |
|
Net income per common share: |
|
|
|
|
|
|
|||
Basic |
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
(3) Adjustment includes a severance charge of |
|
|
Year ended December 31, 2022 |
|||||||
|
|
Reported |
|
Adjustments(4) |
|
Adjusted Non-GAAP |
|||
Operating expenses |
|
|
|
|
$- |
|
|
|
|
% of net sales |
|
55.2 |
% |
|
|
|
55.2 |
% |
|
|
|
|
|
|
|
|
|||
Operating loss |
|
(7,677 |
) |
|
- |
|
(7,677 |
) |
|
% of net sales |
|
(13.2 |
)% |
|
|
|
(13.2 |
)% |
|
|
|
|
|
|
|
|
|||
Interest and other expense |
|
(224 |
) |
|
- |
|
(224 |
) |
|
Loss before income taxes |
|
(7,901 |
) |
|
- |
|
(7,901 |
) |
|
Income tax benefit |
|
1,965 |
|
|
- |
|
1,965 |
|
|
Net loss |
|
(5,936 |
) |
|
- |
|
(5,936 |
) |
|
Net loss per common share: |
|
|
|
|
|
|
|||
Basic |
|
|
) |
|
$- |
|
|
) |
|
Diluted |
|
|
) |
|
$- |
|
|
) |
|
(4) No adjustments. |
TRANSACT TECHNOLOGIES INCORPORATED |
RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA NON-GAAP FINANCIAL MEASURES |
(Preliminary and Unaudited) |
|
|
Three months ended |
|
Year ended |
||||||
|
|
December 31, |
|
December 31, |
||||||
|
|
2023 |
|
|
2022 |
|
2023 |
|
2022 |
|
|
|
(In thousands) |
||||||||
|
|
|
|
|
|
|
|
|
||
Net (loss) income |
|
|
) |
|
|
|
|
|
|
) |
|
|
|
|
|
|
|
|
|
||
Interest expense, net |
|
48 |
|
|
63 |
|
255 |
|
208 |
|
Income tax (benefit) expense |
|
(34 |
) |
|
322 |
|
1,155 |
|
(1,965 |
) |
Depreciation and amortization |
|
386 |
|
|
348 |
|
1,489 |
|
1,332 |
|
|
|
|
|
|
|
|
|
|
||
EBITDA |
|
338 |
|
|
993 |
|
7,647 |
|
(6,361 |
) |
|
|
|
|
|
|
|
|
|
||
Share-based compensation expense |
|
249 |
|
|
287 |
|
860 |
|
1,155 |
|
Severance charge related to resignation of the Company’s former Chief Executive Officer |
|
- |
- | 1,461 | - |
|
||||
|
|
|
|
|
|
|
|
|
||
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
) |
|
|
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312093818/en/
Investor:
Ryan Gardella
ICR, Inc.
Ryan.Gardella@icrinc.com
Source: TransAct Technologies Incorporated